SUMMARY. Bay k 8644 is a structural analog of nifedipine with positive inotropic activity. The mechanism of drug action was evaluated by measuring the effects of Bay k 8644 on twitch tension, action potential configuration, and calcium channel currents in myocardial cells. Bay k 8644 increases twitch tension in guinea pig atria without changing the time course of tension development. The drug does not occlude the effect of isoproterenol on twitch tension. The effects of Bay k 8644 on atrial twitch tension are highly dependent on the frequency of stimulation. Maximal inotropic effects are observed at ~0.5 Hz, but no inotropic effect occurs at 0.003 Hz (a rested-state contraction). Since positive inotropic effects only occur with frequent electrical stimulation, they are not due to an intracellular action or to mechanisms that elevate cell calcium in quiescent muscle, such as inhibition of the Na,K-ATPase. Bay k 8644 increases the action potential duration of calf ventricular muscle and Purkinje fibers. Effects on action potential duration are occluded by 1 MM nisoldipine, which specifically blocks calcium channels. The interaction of Bay k 8644 with calcium channels in calf Purkinje fibers was studied using the twomicroelectrode voltage clamp technique. Strontium was used as a charge carrier to minimize current through calcium-activated channels and to avoid changes in calcium conductance due to changes in intracellular calcium. Bay k 8644 increases strontium currents and alters the time-and voltage-dependence of channel opening. The greatest percent increase in strontium current occurs for weak depolarizations. For strong depolarizations, strontium current is increased most at the beginning of a test pulse. The drug-induced changes in calcium channel gating are inconsistent with a calcium-or cyclic adenosine monophosphate-mediated effect, and indicate a novel mechanism of action on calcium channels. Thus, Bay k 8644 is the first positive inotropic agent shown to act specifically and directly on calcium channels. (Circ Res 56: 87-96, 1985) 
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Four different categories of drug action were tested for by measuring the effects of Bay k 8644 on twitch tension, action potential configuration, and Ca ++ channel currents: (1) an intracellular effect, such as increasing the Ca ++ sensitivity of the myofibrils or altering Ca ++ uptake and release by the sarcoplasmic reticulum; (2) elevation of cell Na + , which results in increased cell Ca ++ due to Na-Ca exchange; (3) a direct effect on Ca ++ channels, resulting in increased Ca ++ influx; and (4) prolongation of the action potential duration by an effect on Na + or K + channels, which indirectly increases current through Ca ++ channels or increases Ca ++ release from the sarcoplasmic reticulum. We found that Bay k 8644 directly interacts with Ca ++ channels to promote Ca ++ entry. No other site of action was detected. The drug represents a new type of positive inotropic agent because it affects Ca ++ channels in a unique way.
Preliminary reports of parts of this work have been published previously Cohen and Chung, 1984) .
Methods

Preparations
Mechanical studies were performed on guinea pig left atria. Pirbright-white guinea pigs (250-300 g) of either sex were killed by a blow to the head. Electrophysiological experiments were performed on calf ventricular trabeculae or Purkinje fibers. Calf hearts were obtained from a local slaughterhouse and transported to the laboratory in icecold physiological saline. Voltage clamp experiments were performed on short segments of Purkinje fibers (~200 nm in diameter and 0.5-1.5 mm long) obtained from either ventricle.
Twitch Tension Measurements
Left atria were separated from the ventricle, suspended in an organ bath, and maintained under a constant resting tension of 0.5-1.0 g. Square pulse field stimuli were 2 msec and 16V (~2.5x threshold). Contractions were measured isometrically with Stratham UC2 strain gauges and recorded with a chart recorder (Hellige) and digital storage oscilloscope .
Voltage Clamp Measurements
Two microelectrode voltage clamp experiments were performed as previously described (Kass et al., 1979) . Command pulses were rounded with a time constant of 100 fisec to reduce cell damage. Membrane current and voltage were filtered with an 8-pole low pass Bessel filter (Frequency Devices) and recorded with an LSI 11/23 computer. Cut-off frequencies and sampling rates are indicated in the appropriate figure legends. In order to equate membrane current with Ca ++ channel current, all current pathways other than Ca ++ channels must be blocked or inactivated. In particular, the transient outward and delayed rectifier currents must be blocked. Previous studies have shown that these currents can be minimized by loading the fibers with Cs + by using nystatin (Marban, 1981) or by injecting quaternary ammonium salts, such as tetrabutylammonium . We used a modification of these techniques: Cs + was injected into the fibers under voltage clamp using current-passing microelectrodes filled with 2.5 M CS acetate plus 1.0 M CsCl. Cs + salts were used instead of tetrabutylammonium salts because they have a higher solubility and ionic mobility, so that outward currents could be passed more readily with unbeveled micropipettes. Cs + was iontophoresed into the fibers until block of outward currents was maximal (~15 minutes). In addition, extracellular Ca ++ and K + were replaced by Sr ++ and Cs + (see composition of solutions below). The Ca ++ -dependent transient outward is only weakly activated by Sr ++ (Siegelbaum and Tsien, 1980; Coraboeuf and Carmeliet, 1982) . The use of Sr ++ as a charge carrier also allowed us to determine whether drugs directly affect Ca ++ channels (see Results). Bay k 8644 is methyl l,4-dihydro-2,6-dimethyl-3-nitro-4-(2-trifluorornethylphenyl)-pyridine-5-carboxylate, and its structure is given in Figure 1 . The structural formula for nifedipine is also shown to illustrate the close structural analogy of these compounds. Bay k 8644, nitrendipine (Bay e 5009), and nisoldipine (Bay k 5552) are all products of Bayer AG. They were dissolved in 40% dimethyl sulfoxide (DMSO) or polyethylene glycol 400 (Baker). Final solvent concentrations in these experiments were <0.03%. The solvents have no effect on Ca ++ channel currents (Kass, 1982) or twitch tension at those low concentrations. Sodium vapor lights were used during experiments with dihydropyridines because the compounds are light sensitive. Isoproterenol sulfate was obtained from Boehringer Ingelheim.
Solutions and Drugs
Results
Positive Inotropic Effects
The effect of Bay k 8644 on twitch tension in guinea pig atria is shown in the top panel of Figure  2 . Twitch tension is approximately doubled after a 5-minute exposure to 280 nM Bay k 8644, with little change in the time course of tension development. Bay k 8644 and elevated external Ca ++ have similar effects on twitch tension (middle panel). In contrast, the /3-adrenoceptor agonist, isoproterenol, shortens the time-to-peak tension and speeds the rate of relaxation (bottom panel). These results suggest that Bay k 8644 is not a sympathomimetic agent. Likewise, the positive inotropic effect of Bay k 8644 is unaffected by propranolol, a /3-adrenoceptor antagonist . Figure 3 further contrasts the inotropic effects of Bay k 8644 and /?-adrenoceptor agonists. This figure shows that maximally effective doses of Bay k 8644 do not occlude the effect of isoproterenol on twitch tension. 1 fiM Bay k 8644 was a maximally effective dose because increasing the concentration to 3 /*M did not have an additional effect on tension. However, 10 nM isoproterenol further increased twitch tension. This result suggests that the two drugs do not share a common mechanism of action. It also indicates that the response to Bay k 8644 had a maximum that was not due to a mechanical limitation.
The positive inotropic effect of Bay k 8644 was studied under a wide range of concentrations and stimulation rates. Figure 4 shows that Bay k 8644 is a very potent positive inotropic agent during 1 Hz stimulation. Increases in cardiac contractility are consistently produced by 10 nM drug, and maximal effects are produced at 1 yM.
The inotropic effects of Bay k 8644 were evaluated in mammalian atrial cells, because insight into the mechanism of drug action is readily obtained from the dependence of inotropy on stimulation rate in this tissue. In these cells, the first contraction after a long rest period (a rested-state contraction) should be insensitive to agents that act primarily on Ca ++ channels, but these contractions are enhanced by positive inotropic agents that alter inrracellular Ca ++ release or load the cell with Ca ++ during rest (see the discussion section for references). This behavior is illustrated in Figures 5 and 6 .
The upper panels of Figure 5 show twitch tension when an atrium was rested for 10 minutes and then stimulated at 1.0 Hz. In each panel, a large rested- continued presence of nitrendipine does alter the rested-state contraction (right panel). The restedstate contractions for all three panels are superimposed on an expanded time scale in the lower panel. Nitrendipine was studied because its specificity for blocking Ca ++ channels in myocardial cells is well documented (Lee and Tsien, 1983; Shibata et al., 1984) , but it alters Ca ++ transport by the sarcoplasmic reticulum only at very high doses (Colvin et al., 1982; Chamberlain et al., 1984) . In contrast, changes in external Ca ++ result in changes in intracellular Ca ++ , even in the absence of electrical stimulation (Sheu and Fozzard, 1982; Lakatta and Lappe, 1981) . Figure 6 shows the result when the same stimulation pattern is applied in the presence of 280 nM Bay k 8644. This dose increases the steady state twitch tension for 1.0 Hz stimulation (as shown in Fig. 2 ) and also increases the second twitch in a train by 20.4%, but does not affect the rested-state contraction (see the lower panel for an expanded time scale). This experiment suggests that the inotropic effect of Bay k 8644 is not due to an intracellular action, or to any mechanism that alters cell Ca ++ at rest, such as inhibition of the Na,K-ATPase.
The effect of Bay k 8644 on the steady state forcefrequency relationship is shown in Figure 7 . Increasing the stimulation rate above 0.2 Hz normally produces a positive force staircase in mammalian atria (Koch-Weser and Blinks, 1963) . Bay k 8644 shifts the positive staircase effect to lower frequencies of stimulation. Consequently, the maximal percent increase in twitch tension occurs for stimulation at about 0.5 Hz.
Electrophysiological Effects
The dependence of the mechanical effects of Bay k 8644 on continual electrical stimulation suggests that the drug alters a sarcolemmal ionic conductance. The nature of the conductance change was explored in electrophysiological studies on calf ventricular muscle and Purkinje fibers. (Dudel et al., 1966; Temte and Davis, 1967; Kass and Tsien, 1976; Colatsky and Hogan, 1980 ; but see Reuter, 1967) or /3-adrenoceptor agonists (Tsien et al., 1972) , which usually decrease the action potential duration. Similar effects of Bay k 8644 on the action potential were seen in one other calf Purkinje fiber and in one rabbit Purkinje fiber.
The effect of Bay k 8644 on action potential duration indicates a decrease in net outward current during repolarization. If the drug affects only inward Ca ++ currents (and, indirectly, Ca ++ -activated outward currents), then a high dose of the specific Ca ++ channel blocker nisoldipine should eliminate the effect of Bay k 8644 on action potential configuration (Kazda et al., 1980; Kass, 1982) . Figure 9 shows a test of this prediction. A Purkinje fiber was exposed to 1 IXM nisoldipine, which shortened the action potential and depessed the plateau height (Kass, 1982) . However, this dose does not alter the delayed rectifier current, I x (Kass, 1982) . 30 nM Bay k 8644 was then added in the continued presence of nisoldipine (a low dose was chosen so as not to reverse the nisoldipine block of Ca ++ channels). No additional change in action potential was observed, in contrast to the result of Figure 8 . A similar result was obtained in another calf Purkinje fiber. (Isenberg, 1977; Weingart et al., 1978; Noble and Shimoni, 1981; Marban and Tsien, 1982; Lederer and Eisner, 1982) . This indirect drug effect on Ca ++ conductance can be eliminated by using Sr ++ as the charge carrier (Marban and Tsien, 1982) . To determine whether Bay k 8644 acts directly on voltage-gated Ca ++ channels to enhance Ca ++ entry, we measured Sr ++ currents with a two-microelectrode voltage clamp in calf Purkinje fibers. Purkinje fibers were used because the effects of other inotropic agents on Ca ++ channels are well characterized in this tissue, and because run-down of Ca ++ currents is negligible. Figure 10 shows the effect of Bay k 8644 on Sr ++ currents (Is r ). Is r was elicited by stepping the membrane potential from -45 to +10 mV. The current recordings show (from top to bottom) the effect of 0.. 30, 100, or 300 nM Bay k 8644. Bay k 8644 increases Is r and changes the time course of channel gating. I Sr is most enhanced immediately after the voltage step, so that large increases in peak I Sr are observed. The rate of current decay is speeded, so that only a small increase in I Sr is observed at the end of the depolarization.
Bay k 8644 could increase peak I Sr and speed the rate of channel inactivation by uniformly shifting the voltage-dependence of channel gating to more negative voltages. Figure 11 indicates that this is not the case. Comparison of the control record at -15 mV with the record at -30 mV in Bay k 8644 suggests a voltage shift of ~15 mV, but other pairwise comparisons indicate much larger effects on the voltage-dependence of channel gating. In general, the time course of I Sr in the presence of 300 nM Bay k 8644 was unlike the current elicited by stronger depolarizations without drug. Figure 12 shows a plot of the peak current measured at each voltage. The maximal inward current was seen at more negative potentials in the presence of Bay k 8644, indicating that the largest percent increase in I Sr was seen for weak depolarizations. This type of change in the current-voltage relationship can occur as an artifact of inadequate voltage control during the current measurement (Jack et al., 1975; chapter 12) . However, the same change in the I-V relationship occurred when the effect of Bay k 8644 on peak current was offset by reducing external Sr ++ from 5.4 to 1.8 mM. Similar effects of Bay k 8644 on the I-V relationship were observed in four other experiments.
Deactivation of Ca
++ channels after repolarization is normally so fast that it occurs while the membrane capacitance is being discharged in this preparation. However, a slow component of this "tail current" can be seen in the presence of Bay k 8644 (this is most easily seen by comparing the two current recordings at +15 mV after repolarization in Fig. 11 ). These tail currents are blocked by nisoldipine with the same potency as the inward current during the test pulse, indicating that they are through Ca ++ channels (unpublished results).
Discussion
Mechanism of Drug Action
Earlier contractility studies from this laboratory suggested that Bay k 8644 acts on the same Ca ++ channels as nifedipine, but that the two dihydropyridines have a diametrically opposite effect on these channels: nifedipine blocks the channels, while Bay k 8644 enhances Ca ++ entry . The voltage clamp experiments presented in this paper provide direct experimental support for this idea. Bay k 8644 directly interacts with Ca ++ channels to increase Ca ++ entry into myocardial cells. Our findings are consistent with ligand binding studies with fH]-Bay k 8644, which indicate that the drug acts at the same site as nitrendipine and nifedipine (Bellemann, 1984; Janis et al., 1984) . Similar electrophysiological findings have recently been reported by others (Hess et al., 1984; Sanguinetti and Kass, 1984; Ochi et al., 1984) . The lack of effect of Bay k 8644 on atrial rested state contractions indicates that the drug does not alter cell Ca ++ in the absence of electrical activity. This distinguishes Bay k 8644 from cardiac glycosides, which increase these contractions (KochWeser and Blinks, 1962; Tuttle and Farah, 1962; Vincenzi, 1967) , presumably because inhibition of the sodium pump increases intracellular Ca ++ even at rest (Bers and Ellis, 1982; Sheu and 1982). It also distinguishes Bay k 8644 from a number of cardiotonic agents that alter the intracellular transport or binding of Ca ++ , such as caffeine (Lewartowski et al., 1978) , ryanodine (Frank and Sleator, 1975) , metabolic inhibitors (Katzung et al., 1957) , isoproterenol (G. Thomas, unpublished observations) , and phosphodiesterase inhibitors (Reinhardt et al., 1977) . Hence, the positive inotropic effect of Bay k 8644 is not due to inhibition of the Na,K-ATPase or to increased sensitivity of the myofibrils to Ca ++ . The effects of nitrendipine and Bay k 8644 on twitch tension further clarify the role of Ca ++ channels in atrial muscle. Although tension development at physiological stimulation rates is sensitive to changes in I Ca / this source of Ca ++ seems to play a minor role in atrial rested-state contractions. For example, Ni ++ has a small effect on rested-state contractions at concentrations that block a substantial fraction of I Ca (Lewartowski et al., 1978) . Nitrendipine is a more specific blocker of Ca ++ channels than drugs previously used to characterize atrial rested state contractions. Nitrendipine, 830 nM, should block a significant fraction of Ic a at all stimulation rates, although more block is likely at faster rates of stimulation (Lee and Tsien, 1983; Sanguinetti and Kass, 1984) . This dose had no effect on rested-state contractions, but had a pronounced effect during 1 Hz stimulation (Fig. 5; Kass and Sanguinetti (1984) found that nitrendipine block of Ic a is much less after rest in a well-polarized cell than during constant stimulation. This can account, in part, for the greater drug effect during 1 Hz stimulation). Hence, the activating Ca ++ for atrial restedstate contractions is almost entirely from intracellular Ca ++ stores. Either I Ca is unimportant in supplying Ca ++ for tension development in rested-state contractions, or a small fraction of I Ca can trigger maximal Ca ++ release from the sarcoplasmic reticulum in atrial cells (Fabiato and Fabiato, 1978) . The lack of effect of Bay k 8644 on rested-state contractions is consistent with these ideas. Excitation-contraction coupling is qualitatively different in ventricular cells, where rested-state contractions are sensitive to changes in Ic a (Lewartowski et al., 1978; G. Thomas, unpublished results) .
Most agents that increase I Ca exert their effect by increasing cyclic AMP. However, the electrical and mechanical effects of Bay k 8644 are not consistent with a cyclic AMP-mediated mechanism: (1) maximally effective doses of Bay k 8644 do not occlude the inotropic effects of isoproterenol (Fig. 3) . This indicates that the two drugs do not share a common pathway for modifying Ca ++ channel function. (2) Agents that increase cyclic AMP also speed the rate of Ca ++ uptake by the sarcoplasmic reticulum (Fabiato and Fabiato, 1975b; Tada and Katz, 1982) and increase the delayed rectifier K + channel current (I x ) (Tsien et al., 1972) . Bay k 8644 does not speed the rate of relaxation of tension (Fig. 2) , suggesting a lack of effect on Ca ++ uptake by the sarcoplasmic reticulum. Furthermore, Bay k 8644 increases the action potential duration over a broad concentration range, but /3-adrenoceptor agonists can decrease the action potential duration due to enhanced I x (Tsien et al., 1972; Kass and Wiegers, 1982) . (3) j3-Adrenoceptor agonists or intracellular injection of cyclic AMP increase the magnitude of Ic a with little change in the time-or voltage-dependence of channel gating [Noma et al., 1980; Isenberg and Klockner, 1982; Kass and Wiegers, 1982; but Bean et al. (1984) found that the rate of activation is slowed by isoproterenol, and the peak of the I-V is at more negative voltages]. Agents that increase Ic a by changing cell Ca ++ also produce a scalar increase in current (Marban and Tsien, 1982) . In contrast, Bay k 8644 increases the peak Ca ++ channel current, with the largest increases occurring at potentials where the probability for channel opening is normally very low. For stronger depolarizations (to potentials spanned by the plateau of the action potential), the rate of current decay is increased, so that the current is increased most at the beginning of a test pulse or action potential (see Figs. 10 and 11) (Smith, 1975; Braunwald et al., 1976, chapter 12; Hamer, 1979; Fleckenstein, 1983) . Most of the currently available cardiotonic agents are plagued by the difficulties associated with Ca ++ overload and, consequently, have a low therapeutic index. Katz has even suggested that this problem is inherent to positive inotropic agents, and questions the usefulness of new drugs of this type (Katz, 1978) .
Bay k 8644 is a particularly interesting drug because it increases I Ca in a unique way that should allow the extra Ca ++ influx to be used very efficiently. Consequently, less Ca ++ entry should be needed to achieve a given inotropic effect. As discussed above, Bay k 8644 increases Ca ++ entry primarily during the first 50 msec of systole, with smaller increases taking place during the action potential plateau, and probably no increment in influx during diastole. Recent studies suggest that Ca ++ entry at the beginning of an action potential has a greater effect on tension development than entry at other times.
Simultaneous measurements of tension and I Ca under voltage clamp indicate that Ca ++ entry throughout the action potential is important for tension development (Beeler and Reuter, 1970; Gibbons and Fozzard, 1975; Wier and Isenberg, 1982) . However, two studies indicate that Ca ++ entry during the action potential plateau is used for loading intracellular stores of Ca ++ and affects tension development only on subsequent beats, whereas Ca"^+ release from these stores is determined only by the first few milliseconds of depolarization: (1) twitch tension is not increased when test pulses are made longer than 100 msec if the effects of prior electrical stimulation are eliminated by a long rest period (Gibbons and Fozzard, 1971) ; (2) a 50-msec depolarization elicits as much tension as a 500-msec depolarization immediately after a change in pulse duration (Wier and Isenberg, 1982; compare Fig. 5, a and d) .
The Ca ++ influx occurring during the first few milliseconds of a cardiac action potential is only a small fraction of the Ca ++ that activates myofibrils (Wier and Isenberg, 1982; Fabiato, 1983; Malloy and Morad, 1984) , but is likely to serve as a trigger for the intracellular release of Ca ++ (Fabiato and Fabiato, 1975a) . Ca ++ -induced Ca ++ release from the sarcoplasmic reticulum is a graded function of the activating Ca ++ concentration, rather than an all-ornothing process (Fabiato and Fabiato, 1975a; Fa-biato, 1983) . Hence, the increase in Ca ++ entry produced by Bay k 8644 should be amplified by increased release of Ca ++ from the sarcoplasmic reticulum.
Agents that alter I Ca via cyclic AMP are prone to produce Ca ++ overload for three reasons: (1) Ca ++ entry is not preferentially increased at the beginning of systole, so that Ca ++ release from the sarcoplasmic reticulum is not optimized; (2) the sensitivity of myofibrils to Ca ++ is reduced, so that a greater increment in intracellular Ca ++ must occur for a given inotropic effect [Ray and England, 1976; McClellan and Winegrad, 1978; Allen and Kurihara, 1980; Marban et al., 1980; but Fabiato and Fabiato (1975b) did not find this effect]; and (3) the positive inotropic effect of increased cyclic AMP is always accompanied by an increase in heart rate. Bay k 8644 has none of these effects, and, thus, offers a promising new way to increase cardiac output. Unfortunately, Bay k 8644 is not clinically useful because it increases coronary resistance, apparently by a direct effect on vascular smooth muscle . Although it is uncertain whether the vasoconstrictor properties of these dihydropyridines can be eliminated, it is clear that the discovery of superior positive inotropic agents is, in principle, possible.
Bay k 8644 is the most specific positive inotropic agent for increasing Ca ++ channel currents. As such, it should be a useful pharmacological tool for defining the role of Ca ++ in physiological processes, complementing the use of the Ca ++ channel blockers.
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